Cancellation of state registration. Epivir

June 1, 2016
Active substances:
Trade names:
ICD-10:
I.B20-B24.B24    Disease caused by human immunodeficiency virus [HIV], unspecified
Epivir, lamivudine, HIV infection, HIV, immunodeficiency, antiviral HIV agent

Russian Ministry of Health in accordance with Article 32 of the Federal Law of 12.04.2010 number 61-FZ "On Circulation of Medicines" decided to cancel state registration and exclusion from the state register of medicines for medical use of the drug(registration certificate LP-000695 dated September 28, 2011 issued by VeeV Healsker UK Limited, United Kingdom):

Epivir (trade name of the medicinal product)

Lamivudine (international non-proprietary or chemical name of the medicinal product)

film-coated tablets, 300 mg (dosage form, dosage)

Glaxo United Kingdom Limited, United Kingdom Priory Street, Ware, Herdfordshire, SGI2 0DJ, United Kingdom GlaxoSmithKline Pharmaceuticals SA, Poland Ui. Grunwaldzka, 189, 60-322, Poznan (name and address of the location of the manufacturer of the medicinal product)

on the basis of filing an application by an authorized legal entity of ZAO GlaxoSmithKline Trading to cancel the state registration of the medicinal product.